{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:45:36Z","timestamp":1794847536412,"version":"4.9.1"},"reference-count":55,"publisher":"American Association for Cancer Research (AACR)","issue":"8","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH1 R01 HL125703"],"award-info":[{"award-number":["NIH1 R01 HL125703"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA204441"],"award-info":[{"award-number":["R01CA204441"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21CA191679"],"award-info":[{"award-number":["R21CA191679"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K25 EB016673"],"award-info":[{"award-number":["K25 EB016673"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748-50"],"award-info":[{"award-number":["P30 CA008748-50"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science Foundation's Integrative Graduate Education and Research Traineeship","award":["IGERT 0965983"],"award-info":[{"award-number":["IGERT 0965983"]}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["S. Kossatz"],"award-info":[{"award-number":["S. Kossatz"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diffuse intrinsic pontine glioma (DIPG) is a childhood brainstem tumor with a universally poor prognosis. Here, we characterize a positron emission tomography (PET) probe for imaging DIPG in vivo. In human histological tissues, the probes target, PARP1, was highly expressed in DIPG compared to normal brain. PET imaging allowed for the sensitive detection of DIPG in a genetically engineered mouse model, and probe uptake correlated to histologically determined tumor infiltration. Imaging with the sister fluorescence agent revealed that uptake was confined to proliferating, PARP1-expressing cells. Comparison with other imaging technologies revealed remarkable accuracy of our biomarker approach. We subsequently demonstrated that serial imaging of DIPG in mouse models enables monitoring of tumor growth, as shown in modeling of tumor progression. Overall, this validated method for quantifying DIPG burden would serve useful in monitoring treatment response in early phase clinical trials. Cancer Res; 77(8); 2112\u201323. \u00a92017 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-16-2850","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T21:50:51Z","timestamp":1484949051000},"page":"2112-2123","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models"],"prefix":"10.1158","volume":"77","author":[{"given":"Susanne","family":"Kossatz","sequence":"first","affiliation":[{"name":"1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Carney","sequence":"additional","affiliation":[{"name":"1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"2Department of Chemistry, Hunter College and PhD Program in Chemistry, The Graduate Center of the City University of New York, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Schweitzer","sequence":"additional","affiliation":[{"name":"3Department of Neurological Surgery, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carlucci","sequence":"additional","affiliation":[{"name":"1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesselin Z.","family":"Miloushev","sequence":"additional","affiliation":[{"name":"1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"4Department of Radiology, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday B.","family":"Maachani","sequence":"additional","affiliation":[{"name":"3Department of Neurological Surgery, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajwal","family":"Rajappa","sequence":"additional","affiliation":[{"name":"3Department of Neurological Surgery, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayvan R.","family":"Keshari","sequence":"additional","affiliation":[{"name":"1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"4Department of Radiology, Weill Cornell Medical College, New York, New York."},{"name":"5Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pisapia","sequence":"additional","affiliation":[{"name":"6Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang A.","family":"Weber","sequence":"additional","affiliation":[{"name":"1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"4Department of Radiology, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Souweidane","sequence":"additional","affiliation":[{"name":"3Department of Neurological Surgery, Weill Cornell Medical College, New York, New York."},{"name":"7Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiner","sequence":"additional","affiliation":[{"name":"1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"4Department of Radiology, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"2022061706165448900_bib1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jnci\/djr077","article-title":"Annual report to the nation on the status of cancer, 1975\u20132007, featuring tumors of the brain and other nervous system","volume":"103","author":"Kohler","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2022061706165448900_bib2","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012","volume":"17","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"key":"2022061706165448900_bib3","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1200\/JCO.2009.27.0421","article-title":"Outcomes for children and adolescents with cancer: challenges for the twenty-first century","volume":"28","author":"Smith","year":"2010","journal-title":"J Clin Oncol"},{"key":"2022061706165448900_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00381-013-2307-1","article-title":"Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis","volume":"30","author":"Patel","year":"2014","journal-title":"Child Nerv Syst"},{"key":"2022061706165448900_bib5","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/foc.2006.20.4.E1","article-title":"Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001","volume":"20","author":"Deorah","year":"2006","journal-title":"Neurosurg Focus"},{"key":"2022061706165448900_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"key":"2022061706165448900_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/neuonc\/noq202","article-title":"Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas","volume":"13","author":"Haas-Kogan","year":"2011","journal-title":"Neuro Oncol"},{"key":"2022061706165448900_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijrobp.2009.04.031","article-title":"Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"77","author":"Jalali","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022061706165448900_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/pbc.21154","article-title":"Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study","volume":"50","author":"Korones","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"2022061706165448900_bib10","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.ejca.2010.06.115","article-title":"A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma","volume":"46","author":"Sharp","year":"2010","journal-title":"Eur J Cancer"},{"key":"2022061706165448900_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-010-0141-9","article-title":"The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma","volume":"100","author":"Michalski","year":"2010","journal-title":"J Neurooncol"},{"key":"2022061706165448900_bib12","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/1097-0142(19930815)72:4<1404::AID-CNCR2820720441>3.0.CO;2-G","article-title":"Preirradation chemotherapy and hyperfractionated radiation-therapy 66 Gy for children with brain-stem tumors - a phase-II study of the pediatric-oncology-group, protocol 8833","volume":"72","author":"Kretschmar","year":"1993","journal-title":"Cancer"},{"key":"2022061706165448900_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"Hargrave","year":"2006","journal-title":"Lancet Oncol"},{"key":"2022061706165448900_bib14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00247-009-1368-5","article-title":"Conventional MRI at presentation does not predict clinical response to radiation therapy in children with diffuse pontine glioma","volume":"39","author":"Liu","year":"2009","journal-title":"Pediatr Radiol"},{"key":"2022061706165448900_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11060-007-9473-5","article-title":"Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma","volume":"86","author":"Hargrave","year":"2008","journal-title":"J Neurooncol"},{"key":"2022061706165448900_bib16","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"key":"2022061706165448900_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-015-3306-6","article-title":"DNA damage response markers are differentially expressed in BRCA-mutated breast cancers","volume":"150","author":"Aleskandarany","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2022061706165448900_bib18","first-page":"1163","article-title":"Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer","volume":"2","author":"Bieche","year":"1996","journal-title":"Clin Cancer Res"},{"key":"2022061706165448900_bib19","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/1535-7163.MCT-13-0010","article-title":"PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy","volume":"12","author":"Chow","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"2022061706165448900_bib20","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.4081\/ejh.2012.e9","article-title":"PARP-1 protein expression in glioblastoma multiforme","volume":"56","author":"Galia","year":"2012","journal-title":"Eur J Histochem"},{"key":"2022061706165448900_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10549-014-3230-1","article-title":"Biological and clinical significance of PARP1 protein expression in breast cancer","volume":"149","author":"Green","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2022061706165448900_bib22","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.ejca.2006.01.061","article-title":"Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis","volume":"42","author":"Nosho","year":"2006","journal-title":"Eur J Cancer"},{"key":"2022061706165448900_bib23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/1947601910383418","article-title":"Upregulation of poly (ADP-Ribose) polymerase-1 (PARP1) in triple-negative breast cancer and other primary human tumor types","volume":"1","author":"Ossovskaya","year":"2010","journal-title":"Genes Cancer"},{"key":"2022061706165448900_bib24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.humpath.2005.04.017","article-title":"Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region","volume":"36","author":"Staibano","year":"2005","journal-title":"Hum Pathol"},{"key":"2022061706165448900_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fonc.2015.00147","article-title":"Pathology, molecular genetics, and epigenetics of diffuse intrinsic pontine glioma","volume":"5","author":"Buczkowicz","year":"2015","journal-title":"Front Oncol"},{"key":"2022061706165448900_bib26","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.1073\/pnas.94.14.7303","article-title":"Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells","volume":"94","author":"deMurcia","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706165448900_bib27","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/neuonc\/nor115","article-title":"Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic target","volume":"13","author":"Smith","year":"2011","journal-title":"Neuro Oncol"},{"key":"2022061706165448900_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0301-472X(03)00083-3","article-title":"PARP-1, a determinant of cell survival in response to DNA damage","volume":"31","author":"Bouchard","year":"2003","journal-title":"Exp Hematol"},{"key":"2022061706165448900_bib29","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/annonc\/mdr361","article-title":"Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer","volume":"23","author":"Rojo","year":"2012","journal-title":"Ann Oncol"},{"key":"2022061706165448900_bib30","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1093\/annonc\/mdv393","article-title":"Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non\u2013small cell lung cancer","volume":"26","author":"Michels","year":"2015","journal-title":"Ann Oncol"},{"key":"2022061706165448900_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tranon.2015.04.004","article-title":"Expression of DNA damage response molecules PARP1, gamma H2AX, BRCA1, and BRCA2 predicts poor survival of breast carcinoma patients","volume":"8","author":"Park","year":"2015","journal-title":"Transl Oncol"},{"key":"2022061706165448900_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1593\/neo.12414","article-title":"Imaging therapeutic PARP inhibition in vivo through bioorthogonally developed companion imaging agents","volume":"14","author":"Reiner","year":"2012","journal-title":"Neoplasia"},{"key":"2022061706165448900_bib33","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/ncomms2506","article-title":"Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo","volume":"4","author":"Thurber","year":"2013","journal-title":"Nat Commun"},{"key":"2022061706165448900_bib34","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1535-7163.MCT-13-0801","article-title":"Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitors","volume":"13","author":"Thurber","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"2022061706165448900_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.neo.2014.05.005","article-title":"PARPi-FL\u2013a fluorescent PARP1 inhibitor for glioblastoma imaging","volume":"16","author":"Irwin","year":"2014","journal-title":"Neoplasia"},{"key":"2022061706165448900_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s11307-015-0904-y","article-title":"Non-invasive PET imaging of PARP1 expression in glioblastoma models","author":"Carney","year":"2016","journal-title":"Mol Imaging Biol"},{"key":"2022061706165448900_bib37","doi-asserted-by":"crossref","first-page":"21371","DOI":"10.1038\/srep21371","article-title":"Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent","volume":"6","author":"Kossatz","year":"2016","journal-title":"Sci Rep"},{"key":"2022061706165448900_bib38","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1158\/0008-5472.CAN-09-2503","article-title":"Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma","volume":"70","author":"Becher","year":"2010","journal-title":"Cancer Res"},{"key":"2022061706165448900_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1593\/tlo.09100","article-title":"Modeling adult gliomas using RCAS\/t-va technology","volume":"2","author":"Hambardzumyan","year":"2009","journal-title":"Transl Oncol"},{"key":"2022061706165448900_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00259-003-1377-9","article-title":"Kinetics of [(11)C]choline uptake in prostate cancer: a PET study","volume":"31","author":"Sutinen","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2022061706165448900_bib41","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s00259-009-1346-z","article-title":"Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data","volume":"37","author":"Tolvanen","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2022061706165448900_bib42","first-page":"1228","article-title":"Automated FLT synthesis using 3-N-Boc-1-(5-O-(4,4\u2032-dimethoxytrityl)-3-O-nosyl-2-deoxy-beta-D-lyxofuranosyl)thymine as precursor","volume":"28","author":"Mosdzianowski","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"2022061706165448900_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0969-8051(01)00289-X","article-title":"A new precursor for the radiosynthesis of [F-18]FLT","volume":"29","author":"Martin","year":"2002","journal-title":"Nucl Med Biol"},{"key":"2022061706165448900_bib44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00401-014-1319-6","article-title":"Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications","volume":"128","author":"Buczkowicz","year":"2014","journal-title":"Acta Neuropathol"},{"key":"2022061706165448900_bib45","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1038\/ncomms11185","article-title":"Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma","volume":"7","author":"Nikbakht","year":"2016","journal-title":"Nat Commun"},{"key":"2022061706165448900_bib46","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0715-827a","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"key":"2022061706165448900_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fonc.2012.00205","article-title":"Diffuse intrinsic pontine glioma: poised for progress","volume":"2","author":"Warren","year":"2012","journal-title":"Front Oncol"},{"key":"2022061706165448900_bib48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"key":"2022061706165448900_bib49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11060-012-0973-6","article-title":"Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment","volume":"110","author":"Hashizume","year":"2012","journal-title":"J Neurooncol"},{"key":"2022061706165448900_bib50","first-page":"1026","article-title":"Magnetic-resonance scans should replace biopsies for the diagnosis of diffuse brain-stem gliomas\u2014a Report from the Childrens Cancer Group","volume":"33","author":"Albright","year":"1993","journal-title":"Neurosurgery"},{"key":"2022061706165448900_bib51","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1200\/JCO.2014.58.8848","article-title":"Poly (ADP-Ribose) polymerase inhibitors: recent advances and future development","volume":"33","author":"Scott","year":"2015","journal-title":"J Clin Oncol"},{"key":"2022061706165448900_bib52","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/1535-7163.MCT-15-0282","article-title":"Poly-ADP-ribose polymerase as a therapeutic target in pediatric diffuse intrinsic pontine glioma and pediatric high-grade astrocytoma","volume":"14","author":"Chornenkyy","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"2022061706165448900_bib53","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jmri.20335","article-title":"Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema","volume":"21","author":"Oh","year":"2005","journal-title":"J Magn Reson Imaging"},{"key":"2022061706165448900_bib54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/neuonc\/noq200","article-title":"MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC)","volume":"13","author":"Poussaint","year":"2011","journal-title":"Neuro Oncol"},{"key":"2022061706165448900_bib55","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00234-016-1724-8","article-title":"Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies","volume":"58","author":"Lobel","year":"2016","journal-title":"Neuroradiology"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/77\/8\/2112\/2761569\/2112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/77\/8\/2112\/2761569\/2112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:59:18Z","timestamp":1655474358000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/77\/8\/2112\/624852\/Biomarker-Based-PET-Imaging-of-Diffuse-Intrinsic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,4,13]]},"published-print":{"date-parts":[[2017,4,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-16-2850","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22416203.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416185.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416188.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416188","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6509483.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416197","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416182.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416185","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416194","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6509483","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416182","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416191","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416200","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416200.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416203","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416191.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416194.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22416197.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}